Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
227.1 USD | +0.92% |
|
-2.04% | -11.89% |
07-16 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
07-16 | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.89% | 32.76B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
+79.40% | 29.46B | |
-12.23% | 16.31B | |
+2.40% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.65% | 8.97B | |
-56.13% | 8.84B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on February 11, 2011.